Henkel
This article was originally published in The Rose Sheet
Executive Summary
German consumer goods company plans to implement €400 mil. restructuring program between 2004-2006. Effort, which comes on top of restructuring already planned for 2004, is expected to yield savings of €125 mil. per year starting in 2007, Henkel announces. Program will aim to reorganize production sites, streamline administrative departments and accelerate recent acquisitions, with a primary focus on Europe and North America. Program will result in the loss of 3,000 jobs worldwide by 2006, Henkel adds. The company implemented another restructuring initiative in 2001 (1"The Rose Sheet" Nov. 19, 2001, p. 11)...
You may also be interested in...
Henkel North American Cosmetics Business Restructuring Planned
Henkel's North American cosmetics and toiletries business will undergo a restructuring aimed at substantial cost reductions, the company noted in a Nov. 12 presentation to analysts. The business includes California-based Schwarzkopf & Dep and the Canadian Schwarzkopf Professional salon supplier
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.
How Ochre Bio Bagged Boehringer For Its RNA-Based Regenerative MASH Therapies
UK-based Ochre Bio has signed its first major deal with Boehringer Ingelheim. Scrip talked to its co-founder and CEO, Jack O’Meara, about its human tissue-based drug discovery platform, its resulting RNA platform for liver disease and how the fledgling drug company's early work mirrored that seen in diagnostics.